Back
Smith & Nephew plc Vs. Akari Therapeutics Plc Industry Stock Comparison
Sell
39
SNNUF
Smith & Nephew plc
Last Price:
$16.50
Seasonality Move:
-3.71%
Sell
25
AKTX
Akari Therapeutics Plc
Last Price:
$0.30
Seasonality Move:
-23.49%
Sell
39
Smith & Nephew plc (SNNUF)
is a Sell
Is Smith & Nephew plc a Buy, Sell or Hold?
-
The current Smith & Nephew plc [SNNUF] share price is $16.50. The Score for SNNUF is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
-
SNNUF is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
25
Akari Therapeutics Plc (AKTX)
is a Sell
Is Akari Therapeutics Plc a Buy, Sell or Hold?
-
The current Akari Therapeutics Plc [AKTX] share price is $0.29. The Score for AKTX is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
-
AKTX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
SNNUF Stock Price Chart
What is Smith & Nephew plc's stock price today?
-
The Smith & Nephew plc share price today is $16.50Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SNNUF is experiencing slight buying pressure.
AKTX Stock Price Chart
What is Akari Therapeutics Plc's stock price today?
-
The Akari Therapeutics Plc share price today is $0.29Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AKTX is experiencing buying pressure, which is a positive indicator for future bullish movement.
SNNUF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 4.39 | Buy |
| Relative Strength Index (14 RSI): | 70.87 | Buy |
| Chaikin Money Flow: | 0 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (14.68 - 16.1) | Buy |
| Bollinger Bands (100): | (15.73 - 17.87) | Sell |
AKTX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.07 | Sell |
| Relative Strength Index (14 RSI): | 38.78 | Sell |
| Chaikin Money Flow: | 793886 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.27 - 0.41) | Sell |
| Bollinger Bands (100): | (0.45 - 0.95) | Sell |
SNNUF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 16.05 | Buy |
| 20-day SMA: | 15.28 | Buy |
| 50-day SMA: | 15.96 | Buy |
| 200-day SMA: | 15.65 | Buy |
| 8-day EMA: | 15.12 | Buy |
| 20-day EMA: | 10.67 | Buy |
| 50-day EMA: | 5.67 | Buy |
| 200-day EMA: | 1.66 | Buy |
AKTX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.27 | Buy |
| 20-day SMA: | 0.31 | Sell |
| 50-day SMA: | 0.49 | Sell |
| 200-day SMA: | 0.96 | Sell |
| 8-day EMA: | 0.28 | Buy |
| 20-day EMA: | 0.33 | Sell |
| 50-day EMA: | 0.47 | Sell |
| 200-day EMA: | 0.94 | Sell |
Smith & Nephew plc Earnings Growth & SNNUF Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Akari Therapeutics Plc Earnings Growth & AKTX Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.03 per share, and a decrease next year of $0.05 per share.
Smith & Nephew plc Technical Analysis
| Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | Jan 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 18 | 19 | 22 | 23 | 24 | 26 | 29 | 30 | 31 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Akari Therapeutics Plc Technical Analysis
| Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 16 | 17 | 18 | 19 | 22 | 24 | 26 | 29 | 30 | 31 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||